A pooled analysis by researchers at Masonic Cancer Centre, University of Minnesota in US covered 13 studies, using data from the Childhood Leukaemia International Consortium (CLIC).
The analysis looked at 33,571 subjects overall, including 23,351 control subjects and 8,655 cases of ALL. The analyses were controlled for a number of outside factors, including breastfeeding, parental education levels, and ethnicity.
After looking most closely at deliveries where the reason for cesarean were available, no link was found between emergency cesareans and ALL or Acute myeloid leukaemia (AML).
"Our goal was to determine if there was an association between cesarean deliveries and ALL, to identify potential new targets for research into cancer prevention if there is a correlation," said Erin Marcotte, assistant professor at University of Minnesota.
"While the link between overall cesarean delivery and childhood leukaemia was not statistically significant, it was notable to find an association between pre-labour cesarean delivery and ALL," Marcotte said.
Several mechanisms may be at play, including the stress response in the foetus caused by labour and the colonisation of microbiota a newborn experiences during a vaginal delivery that is missed during a cesarean birth.
"The most plausible explanation for the association between ALL and pre-labour cesarean delivery is in the cortisol, or stress-related, mechanism," said Marcotte.
"Because ALL is not associated with all cesarean deliveries, it seems less likely the microbiota colonisation is a significant factor in this phenomenon," Marcotte said.
Researchers note the strength of association in these findings is comparable to other studies looking at cesarean delivery rates and other childhood outcomes, including Type I diabetes and asthma.
"We also know that some are born with cells that are on the path to becoming leukaemia. Thus, our working hypothesis is that cortisol exposure at birth may eliminate these pre-leukemic cells," Spector said.
The study was published in the journal The Lancet Haematology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
